• 已选条件：
  • × Molecular Cance
  • × PD-L1
 全选  【符合条件的数据共：11条】

1 Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials [期刊论文]

来源：Molecular Cancer , 2023

作者:Wentao Tian;Ziqi Wang;Jing Zhang;等

关键词:Immune checkpoint inhibitors;TIGIT;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

2 Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials [期刊论文]

来源：Molecular Cancer , 2023

作者:Wentao Tian;Ziqi Wang;Jing Zhang;等

关键词:Immune checkpoint inhibitors;TIGIT;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

3 Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies [期刊论文]

来源：Molecular Cancer , 2023

作者:Łukasz Berlicki;Agnieszka Ciesiołkiewicz;Malgorzata Stec;等

关键词:PD-1;Programmed death 1;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

4 Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma [期刊论文]

来源：Molecular Cancer , 2022

作者:Alessandra Quarta;Gabriella Guida;Roberta Di Fonte;等

关键词:Metastatic melanoma;Drug resistance;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

5 GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma [期刊论文]

来源：Molecular Cancer , 2021

作者:Hui-qiang Huang;Qi-xiang Rong;Hong Zhang;等

关键词:GM-CSF;PD-L1;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

6 N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer [期刊论文]

来源：Molecular Cancer , 2021

作者:Yunlang She;Tingting Wang;Chang Chen;等

关键词:Circular RNA;Non-small-cell lung carcinoma;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]